MED12 Back

mediator complex subunit 12

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of MED12

The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome.

Community Annotation of MED12 Add / Edit MED12: Annotations

No community annotations yet for MED12.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes

• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


MED12 is highly significantly mutated in
MED12 is significantly mutated in
5 patients (3%)
MED12 is near significance in
Chronic lymphocytic leukemia
4 patients (2%)

Click on a tumor type to see its full list of significant genes.

Data details

Mutation list for MED12